Breast Cancer, Cervical Cancer, Esophageal Cancer, Gastric Cancer, Head & Neck Cancer, Lung Cancer, Urothelial Cancer

Welcome to the Dialogues in CDx Podcast

In this new podcast series, Agilent brings together leading pathologists, oncologists, and CDx specialists to explore key challenges and solutions in the field of companion diagnostics. Through peer-to-peer discussions, these experts share fresh insights, real-world approaches, and the latest developments shaping the field. This podcast series is for pathologists, oncologists, and others with a professional interest in the pivotal issues shaping the field of companion diagnostics. 

 

Tune in to Dialogues in CDx for impactful, expert-led conversations across multiple disciplines. The series is accessible on major podcast platforms and can also be viewed on YouTube.

 

The podcast is hosted by Scott W. Boyer, PhD, MBA. Scott is a global product manager at Agilent Technologies, overseeing CDx products and advocating for customer needs. With expertise in the development of both IHC- and PCR-based diagnostics, Scott has published over a dozen peer-reviewed papers in hematology and immunology. Join Scott and renowned guests for insightful discussions on product innovation and diagnostics.  

Scott Boyer, PhD, MBA

Global Product Manager, Agilent Technologies


Related Training

The views and opinions expressed by the guests on this podcast are their own and do not necessarily reflect the views or opinions of the host or of Agilent.

This website addresses general principles for CDx scoring and is for education purposes only. Not all cancer indications mentioned are approved worldwide. Please refer to local Instructions for Use for further details.D0130747_1.00